Mesquite Valley Integrated Health offers medically supervised ketamine infusions at our Mesa, Arizona office. A psychiatric consultation helps determine whether this option may be appropriate when previous treatments have not provided adequate relief. Benefits, risks and alternatives should be considered individually; improvement and lasting relief are not guaranteed.
Call 480-509-7738 to ask about an evaluation, treatment availability and payment options.
Ketamine is FDA-approved for anesthesia. Its use for psychiatric conditions is off-label, meaning the FDA has not approved it for those uses. It can cause side effects and requires medical screening and monitoring.
Ketamine infusions and Spravato® (esketamine nasal spray) are different treatments. Spravato has FDA-approved indications for certain adults with depression and specific monitoring requirements. Ketamine infusions are not FDA-approved for psychiatric disorders.
The conditions below are topics to discuss with your provider; listing a condition does not establish that ketamine is appropriate or FDA-approved for it.
Your provider will review your diagnosis, prior medications and therapy, medical history, substance use history and current medications before discussing whether ketamine is an appropriate option.
If previous treatment has not helped, a new evaluation can clarify what to try next. Your care plan may include changes to medication, psychotherapy or other treatments. Ask about the evidence and limitations for your specific condition.
Ketamine affects NMDA receptors involved in glutamate signaling. Its potential antidepressant effects involve complex processes that are still being studied.
A discussion of possible benefits should also cover uncertainty about duration of response and ongoing treatment needs. Your provider will monitor your symptoms and functioning over time.
The number, dose and timing of infusions are individualized. Your provider will explain the proposed schedule, monitoring and follow-up before you decide whether to begin.
Response and duration of benefit vary. Some patients do not improve, and additional treatment may be needed. Contact the team if symptoms worsen or side effects occur.
The clinical team administers the prescribed infusion and monitors you. Ketamine may cause changes in perception, sedation, nausea, blood pressure changes and other side effects. More serious risks can occur, including breathing problems, particularly with other sedating substances. Tell your provider about all medications, supplements and alcohol or other substance use.
Allow time for monitored recovery and follow the discharge instructions provided by your clinician. Arrange transportation home. Do not drive, operate machinery or return to activities requiring alertness until your clinician’s specified restriction has passed.
Ketamine should be considered within an ongoing mental health care plan. Tell your provider about other clinicians involved in your care so treatment and follow-up can be coordinated.
FDA information on ketamine and unapproved uses | Ketamine prescribing information
Phone (appointments): (480) 509-7738
Office Fax: 480-856-9069